Figure 1 from A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study
<p>Efficacy endpoints. <b>A,</b> Percentage of tumor regression grade. <b>B,</b> Tumor regression grade depending on PD-L1 CPS, HER2, and MMR status. <b>C,</b> PFS. <b>D,</b> OS. <b>E,</b> Subgroup analysis for PFS. <b>F,</b&...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Publicado: |
2025
|
| Materias: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|